We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+23.21%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$27.1B
AUM Growth
+$4.43B
Cap. Flow
-$86.6M
Cap. Flow %
-0.32%
Top 10 Hldgs %
21.67%
Holding
2,442
New
109
Increased
1,083
Reduced
1,137
Closed
107

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$40M
2
AGN
Allergan plc
AGN
+$32.5M
3
RTN
Raytheon Company
RTN
+$26M
4
PSA icon
Public Storage
PSA
+$21M
5
ALL icon
Allstate
ALL
+$18.1M

Sector Composition

Rank Sector Weight
1 Technology 24.66%
2 Healthcare 14.4%
3 Financials 13.15%
4 Consumer Discretionary 10.5%
5 Communication Services 9.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPRT icon
1851
Essential Properties Realty Trust
EPRT
$6.76B
$422K ﹤0.01%
28,445
+10,405
+58% +$143K
HCSG icon
1852
Healthcare Services Group
HCSG
$1.58B
$422K ﹤0.01%
17,232
-12,654
-42% -$300K
PACB icon
1853
Pacific Biosciences
PACB
$460M
$422K ﹤0.01%
122,348
+19,173
+19% +$65.3K
PLCE icon
1854
Children's Place
PLCE
$54.3M
$422K ﹤0.01%
+11,276
New +$383K
UAA icon
1855
Under Armour
UAA
$2.91B
$422K ﹤0.01%
43,356
-17,021
-28% -$162K
ABCB icon
1856
Ameris Bancorp
ABCB
$5.88B
$421K ﹤0.01%
17,847
+2,279
+15% +$53.5K
FARO
1857
DELISTED
Faro Technologies
FARO
$421K ﹤0.01%
7,851
+108
+1% +$5.66K
FFIC
1858
DELISTED
Flushing Financial
FFIC
$421K ﹤0.01%
36,558
+7,464
+26% +$85.4K
MSTR icon
1859
Strategy Inc
MSTR
$35.7B
$421K ﹤0.01%
35,610
+7,660
+27% +$93.2K
VNE
1860
DELISTED
Veoneer, Inc.
VNE
$420K ﹤0.01%
39,316
+17,379
+79% +$171K
AZZ icon
1861
AZZ Inc
AZZ
$4.36B
$419K ﹤0.01%
12,203
+3,795
+45% +$116K
FBMS
1862
DELISTED
The First Bancshares, Inc.
FBMS
$418K ﹤0.01%
+18,595
New +$378K
BFS
1863
Saul Centers
BFS
$850M
$415K ﹤0.01%
12,875
+4,621
+56% +$147K
GBT
1864
DELISTED
Global Blood Therapeutics, Inc.
GBT
$415K ﹤0.01%
6,577
+1,112
+20% +$76.3K
ECHO
1865
DELISTED
Echo Global Logistics, Inc.
ECHO
$415K ﹤0.01%
19,216
+508
+3% +$9.55K
IOVA icon
1866
Iovance Biotherapeutics
IOVA
$2.09B
$412K ﹤0.01%
15,002
-1,490
-9% -$49K
RTL
1867
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
$411K ﹤0.01%
51,814
+21,723
+72% +$159K
BANR icon
1868
Banner Corp
BANR
$2.37B
$409K ﹤0.01%
10,759
+3,572
+50% +$127K
KFY icon
1869
Korn Ferry
KFY
$4.18B
$409K ﹤0.01%
13,301
+1,173
+10% +$33.6K
ENV
1870
DELISTED
ENVESTNET, INC.
ENV
$409K ﹤0.01%
5,562
-771
-12% -$50.4K
TRS icon
1871
TriMas Corp
TRS
$1.36B
$408K ﹤0.01%
17,044
-3,050
-15% -$70.1K
AMRX icon
1872
Amneal Pharmaceuticals
AMRX
$5.91B
$407K ﹤0.01%
85,425
-1,087
-1% -$4.48K
EDIT icon
1873
Editas Medicine
EDIT
$413M
$407K ﹤0.01%
13,753
-244
-2% -$6.38K
INVA icon
1874
Innoviva
INVA
$1.57B
$407K ﹤0.01%
29,082
-4,187
-13% -$57K
PLAN
1875
DELISTED
Anaplan, Inc.
PLAN
$406K ﹤0.01%
+8,967
New +$375K

Similar funds

Aperio Group's Q2 2020 Portfolio in Review

As of Q2 2020, Aperio Group held 2,442 positions worth $27.1B, up 20% from $22.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q2 2020 filing shows 109 new, 1,083 increased, 1,137 reduced and 107 closed positions. Its largest new stake was Arconic Corporation: 1,326,595 shares worth $18.5M. The largest sale was AT&T, an estimated $40M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • Aperio Group's largest Q2 2020 buy was Arconic Corporation: 1,326,595 shares worth $18.5M.
  • Aperio Group added most to Amazon in Q2 2020, an estimated $35.6M increase.
  • Aperio Group's biggest Q2 2020 reduction was AT&T, cutting an estimated $40M.
  • Aperio Group fully exited Allergan plc in Q2 2020, selling an estimated $32.5M.
  • Aperio Group's ten largest holdings make up 22% of its $27.1B portfolio in Q2 2020.
  • Aperio Group opened 109 new positions and closed 107 in Q2 2020.
  • Aperio Group's portfolio value rose 20% quarter-over-quarter to $27.1B.

Based on Aperio Group's 13F filing for Q2 2020, filed 13 Aug 2020.